CME Group Files 8-K for Financial Results and Exhibits
Ticker: CME · Form: 8-K · Filed: 2024-02-14T00:00:00.000Z
Sentiment: neutral
Topics: earnings, financial-report, regulatory-filing
Related Tickers: CME
TL;DR
⚡️ **CME Group just filed an 8-K announcing its financial results and exhibits, get ready for the numbers!**
AI Summary
CME GROUP INC. filed an 8-K on February 14, 2024, to report its Results of Operations and Financial Condition, along with related Financial Statements and Exhibits. This filing, with accession number 0001156375-24-000007, indicates the company is making its latest financial performance public. The document serves as a formal announcement of these disclosures, though specific financial figures are not detailed within this initial filing text.
Why It Matters
This 8-K signals that CME Group Inc. is releasing its latest financial performance, providing investors and the market with crucial information to assess the company's health and future prospects. Such disclosures are vital for transparency and informed investment decisions.
Risk Assessment
Risk Level: low — The filing itself is a standard disclosure of financial results and exhibits, not indicating any immediate positive or negative event beyond the routine reporting of financial performance.
Key Players & Entities
- CME GROUP INC. (company) — Registrant and Filer
- UNITED STATES SECURITIES AND EXCHANGE COMMISSION (company) — Regulatory body
- February 14, 2024 (date) — Date of report and earliest event reported
FAQ
What type of SEC filing is this document?
This document is an 8-K, a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Who is the exact name of the registrant for this filing?
The exact name of the registrant is CME GROUP INC.
What is the date of the earliest event reported in this 8-K?
The date of the earliest event reported is February 14, 2024.
What specific items are being reported in this 8-K by CME Group Inc.?
This 8-K reports on 'Results of Operations and Financial Condition' and 'Financial Statements and Exhibits'.
What is the Commission File Number for CME Group Inc.?
The Commission File Number for CME Group Inc. is 001-31553.
From the Filing
0001156375-24-000007.txt : 20240214 0001156375-24-000007.hdr.sgml : 20240214 20240214070818 ACCESSION NUMBER: 0001156375-24-000007 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240214 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240214 DATE AS OF CHANGE: 20240214 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CME GROUP INC. CENTRAL INDEX KEY: 0001156375 STANDARD INDUSTRIAL CLASSIFICATION: SECURITY & COMMODITY BROKERS, DEALERS, EXCHANGES & SERVICES [6200] ORGANIZATION NAME: 02 Finance IRS NUMBER: 364459170 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31553 FILM NUMBER: 24632227 BUSINESS ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 BUSINESS PHONE: 3129301000 MAIL ADDRESS: STREET 1: 20 S. WACKER DR. CITY: CHICAGO STATE: IL ZIP: 60606 FORMER COMPANY: FORMER CONFORMED NAME: CHICAGO MERCANTILE EXCHANGE HOLDINGS INC DATE OF NAME CHANGE: 20010802 8-K 1 cme-20240214.htm 8-K cme-20240214 false 0001156375 0001156375 2024-02-14 2024-02-14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549   _________________________________________________________ FORM 8-K   _________________________________________________________ CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported) February 14, 2024     _________________________________________________________ CME GROUP INC. (Exact Name of Registrant as Specified in its Charter)   _________________________________________________________   Delaware   001-31553   36-4459170 (State or Other Jurisdiction of Incorporation)   (Commission File No.)   (IRS Employer Identification No.)   20 South Wacker Drive Chicago Illinois   60606 (Address of Principal Executive Offices)   (Zip Code) Registrant’s telephone number, including area code: ( 312 )  930-1000 N/A (Former Name or Former Address, if Changed Since Last Report)   ______________________________________________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A.2. below): ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading symbol Name of each exchange on which registered Class A Common Stock CME Nasdaq Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) of this chapter or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company   ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 2.02. Results of Operations and Financial Condition. The information set forth under “Item 2.02. Results Of Operations and Financial Condition,” including the Exhibit attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except